Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer

A prospective study was performed in patients with non-small cell lung cancer (NSCLC) to evaluate the prognostic importance of multiple molecular marker (p53, c-Ki-ras, c-erbB-2) testing. 103 patients with potentially curative resections (RO resection) for NSCLC in histopathological stages I–IIIA we...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Schneider, P M, Praeuer, H W, Stoeltzing, O, Boehm, J, Manning, J, Metzger, R, Fink, U, Wegerer, S, Hoelscher, A H, Roth, J A
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2000
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374666/
https://ncbi.nlm.nih.gov/pubmed/10945494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1287
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires